Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS) was the recipient of a significant increase in short interest in June. As of June 15th, there was short interest totalling 294,700 shares, an increase of 8.1% from the May 31st total of 272,600 shares. Based on an average trading volume of 123,600 shares, the short-interest ratio is currently 2.4 days.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $117.38 on Thursday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $120.53. The company has a market capitalization of $1.92 billion, a P/E ratio of 29.13, a PEG ratio of 1.77 and a beta of 1.01. The stock has a 50 day moving average price of $111.03 and a two-hundred day moving average price of $100.40.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. During the same quarter in the prior year, the company posted $0.84 EPS. Addus HomeCare’s quarterly revenue was up 11.6% compared to the same quarter last year. Analysts expect that Addus HomeCare will post 4.36 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Principal Securities Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter valued at about $26,000. GAMMA Investing LLC bought a new position in shares of Addus HomeCare in the 4th quarter worth approximately $34,000. EntryPoint Capital LLC bought a new position in Addus HomeCare in the first quarter worth $44,000. Assetmark Inc. lifted its position in Addus HomeCare by 33.3% during the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after acquiring an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $214,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ADUS. Macquarie began coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 target price on the stock. TD Cowen upped their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research report on Tuesday, June 18th. Oppenheimer lifted their target price on shares of Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. Finally, Stephens raised their price target on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research report on Friday, May 31st. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $116.25.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.